CVS Health raised its 2025 profit forecast today, signaling steady progress in the health conglomerate’s turnaround plan.

The company has delivered on its promises this year and will now focus on improving consumer experiences across the business, Chief Executive David Joyner said during the CVS investor day.

“We’ve invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust,” he added.

CVS, the parent company of Longs Drugs in Hawaii, also announced the launch of a consumer app that is meant to increase and integrate its services, potentially driving new sources of revenue for its partners.

Shares in CVS, which operates one of the largest U.S. pharmacy chains, rose 2.2% to $78.24 in trading today after the company also raised its 2025 profit

See Full Page